Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

PUBLICATION DATE

33 results
Display

The electroretinographic change by the acute effects of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

Kim DM, Lee J

The electrophysiological effects of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (NMPTP), a chemical inducer of Parkinsonism in man and monkey, on the pigmented rabbit retina were determined under acute conditions. The amplitude of the b-wave...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Role of Axonopathy in Parkinson's Disease

O'Malley K

New genetic and environmental studies of Parkinson's disease have revealed early problems in synaptic function and connectivity indicating that axonal impairment may be an important hallmark in this disorder. Since...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Changes of Locomotor Activity and Biogenic Amines by 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57BL/6 Mice

Heo JH, Kim JS, Bahng HR, Kim DG

  • KMID: 1957291
  • J Korean Neurol Assoc.
  • 1994 Dec;12(4):593-603.
The neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in rodents was investigated by measuring the locomotor activity and the changes of brain biogenic amines in MPTP-treated C57BL/6 mice. The mice showed a typical...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
1alpha,25-Dihydroxyvitamin D3 Protects Dopaminergic Neurons in Rodent Models of Parkinson's Disease through Inhibition of Microglial Activation

Kim JS, Ryu SY, Yun I, Kim WJ, Lee KS, Park JW, Kim YI

BACKGROUND: Recent studies have demonstrated the molecular basis of the immunomodulatory and anti-inflammatory activities of 1,25-dihydroxyvitamin D3(1,25-(OH)2D3). This hormone improves behavioral deficits and normalizes the nigral dopamine levels in animal...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Differential Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on Motor Behavior and Dopamine Levels at Brain Regions in Three Different Mouse Strains

Lee KS, Lee JK, Kim HG, Kim HR

Developing an animal model for a specific disease is very important in the understanding of the underlying mechanism of the disease and allows testing of newly developed new drugs before...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Behavioral and Histochemical Changes in MPTP-treated C57BL/6 Mice: A Model for Parkinson's Disease

Kim JW, Lee SK, Ha KM

  • KMID: 2138112
  • J Korean Neurol Assoc.
  • 1993 Jun;11(2):175-180.
The effects of 1-methyl-4-phenyl-1, 2. 3, 6-tetrahydropyridine (MPTP) on behavioral and histochemical changes were investigated in C57BL/6 mice. For immunocytochemis try, one group of mice received a dose of 2X30mg/kg...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effects of a Silkworm Extract on Dopamine and Monoamine Oxidase-B Activity in an MPTP-induced Parkinsons Disease Model

Kang YK, Oh HS, Cho YH, Kim YJ, Han YG, Nam SH

  • KMID: 2312079
  • Lab Anim Res.
  • 2010 Sep;26(3):287-292.
The protective efficacy of a silkworm extract (SE) on N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinsonism and its possible mechanisms were studied in C57BL/6 mice. Mice were administrated intraperitoneally with SE (20 mg/kg/day) for...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effects of Nicotine on MPTP-induced Parkinson's Disease Animal Model

Kim HJ, Park KH, Oh SO, Kim Y, Yoon S, Baek SY

  • KMID: 1472488
  • Korean J Anat.
  • 2009 Sep;42(3):161-169.
Parkinson's disease (PD) is a progressive neurological disorder characterized by selective loss of dopaminergic neurons in the substantia nigra pars compacta (SNpc). Despite extensive researches, the etiology of this disease...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparative analysis of dose-dependent neurotoxic response to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57BL/6 N mice derived from three different sources

Hwang DJ, Kwon KC, Song HK, Kim KS, Jung YS, Hwang DY, Cho JY

MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine is commonly used to induce nigrostriatal defects to induce parkinsonism and/or parkinsonian syndrome, to replicate the lesions seen in Parkinson's disease (PD), with use in numerous PD models...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Glycyrrhizin Attenuates MPTP Neurotoxicity in Mouse and MPP+-Induced Cell Death in PC12 Cells

Kim YJ, Lee CS

The present study examined the inhibitory effect of licorice compounds glycyrrhizin and a metabolite 18 beta-lycyrrhetinic acid on the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse and on the 1-methyl-4-phenylpyridinium...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Effect of MPTP on Movement and TH-immunoreactive Neuronal Changes of C57BL/6 Mice in Relation to Aging

Kim JW, Baek SY, Yoon HW

  • KMID: 1530497
  • Korean J Anat.
  • 1999 Jun;32(3):421-424.
The effects of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) on movement and tyrosine hydroxylase (TH)-immunoreactive (ir) neuronal changes in young (5~6 weeks) and aged (10~12 months) C57BL/6 mice were studied. Locomotor...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Inhibition of Oxidative Tissue Damage and Mitochondrial Dysfunction by Glycyrrhizin in the 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Mouse Model of Parkinson's Disease

Park SE, Hong KM, Han JH, Kim DE, Lee CS

  • KMID: 2343255
  • J Korean Neurol Assoc.
  • 2007 Aug;25(3):353-363.
BACKGROUND: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) produces an irreversible and severe parkinsonian-like syndrome. A licorice compound glycyrrhizin exerts a cytoprotective or anti-oxidant effect in various disease conditions, but its effect against the MPTP-induced...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effects of (−)-Sesamin on Memory Deficits in MPTP-lesioned Mouse Model of Parkinson's Disease

Zhao TT, Shin KS, Lee MK

This study investigated the effects of (−)-sesamin on memory deficits in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned mouse model of Parkinson's disease (PD). MPTP lesion (30 mg/kg/day, 5 days) in mice showed memory deficits...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Effect of MPTP in The Mouse Brain in Relation to Aging: Immunocytochemical Analysis

Kim JW, Lee SK, Ha KM

  • KMID: 2342392
  • J Korean Neurol Assoc.
  • 1994 Jun;12(2):183-187.
The effect of MPTP on catecholamine neurons in young (4-6 weeks) and aging (10-12 months) C57BL/6 mice was studied using immunocytochemical techniques. Both groups of mice received 4 repeated dosages...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Bee venom phospholipase A2 ameliorates motor dysfunction and modulates microglia activation in Parkinson's disease alpha-synuclein transgenic mice

Ye M, Chung HS, Lee C, Song JH, Shim I, Kim YS, Bae H

α-Synuclein (α-Syn) has a critical role in microglia-mediated neuroinflammation, which leads to the development of Parkinson's disease (PD). Recent studies have shown that bee venom (BV) has beneficial effects on...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Effect of Ginseng Saponin on the Dopaminergic Neurons in the Parkinson's Disease Model in Mice

Kim CO, Kim KS, Huh YB, Ahn BW, Han BS, Choi KS, Nam KY, Juhng SW

  • KMID: 1849798
  • Korean J Pathol.
  • 1997 Sep;31(9):805-814.
Saponin has been known to be a major antioxidant component in panax ginseng. Recent experimental study suggests that some antioxidant materials prevent Parkinson's disease caused by 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) in...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Behavior, PET and Histology in Novel Regimen of MPTP Marmoset Model of Parkinson's Disease for Long-Term Stem Cell Therapy

Yun JW, Ahn JB, Kwon E, Ahn JH, Park HW, Heo H, Park JS, Kim H, Paek SH, Kang BC

Stem cell technologies are particularly attractive in Parkinson's disease (PD) research although they occasionally need long-term treatment for anti-parkinsonian activity. Unfortunately, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) widely used as a model for PD...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Proposed Motor Scoring System in a Porcine Model of Parkinson's Disease induced by Chronic Subcutaneous Injection of MPTP

Moon JH, Kim JH, Im HJ, Lee DS, Park EJ, Song K, Oh HJ, Hyun SB, Kang SC, Kim H, Moon HE, Park HW, Lee HJ, Kim EJ, Kim S, Lee BC, Paek SH

Destruction of dopaminergic neurons in the substantia nigra pars compacta (SNpc) is a common pathophysiology of Parkinson's disease (PD). Characteristics of PD patients include bradykinesia, muscle rigidity, tremor at rest...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Neuroprotective Effect of β-Lapachone in MPTP-Induced Parkinson's Disease Mouse Model: Involvement of Astroglial p-AMPK/Nrf2/HO-1 Signaling Pathways

Park JS, Leem YH, Park JE, Kim DY, Kim HS

Parkinson's disease is a neurodegenerative disease characterized by the progressive loss of dopaminergic neurons within the substantia nigra pars compacta. In the present study, we investigated whether β-Lapachone (β-LAP), a...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Nicotine Prevents MPTP-induced Dopaminergic Neurodegeneration

Kim JM, O JJ, Jeon BS

Epidemiological studies of Parkinson disease (PD) have found an inverse correlation between cigarette smoking and the risk of developing PD, which suggests that nicotine has a protective effect. Results from...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr